NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 77 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $345,000 | +35.3% | 2,498,050 | +0.3% | 0.00% | – |
| Q4 2018 | $255,000 | -55.5% | 2,491,075 | +0.3% | 0.00% | – |
| Q3 2018 | $573,000 | +1.2% | 2,482,420 | +0.1% | 0.00% | – |
| Q2 2018 | $566,000 | -36.5% | 2,480,065 | +0.2% | 0.00% | – |
| Q1 2018 | $891,000 | -0.1% | 2,474,725 | -0.6% | 0.00% | – |
| Q4 2017 | $892,000 | -13.6% | 2,490,296 | +0.1% | 0.00% | – |
| Q3 2017 | $1,032,000 | -18.4% | 2,486,756 | +0.2% | 0.00% | – |
| Q2 2017 | $1,265,000 | -30.1% | 2,480,771 | -21.0% | 0.00% | – |
| Q1 2017 | $1,810,000 | – | 3,138,641 | +313864000.0% | 0.00% | – |
| Q4 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2016 | $11,000 | +57.1% | 11,917 | +119.3% | 0.00% | – |
| Q4 2015 | $7,000 | +133.3% | 5,433 | +279.1% | 0.00% | – |
| Q3 2015 | $3,000 | -57.1% | 1,433 | -67.4% | 0.00% | – |
| Q2 2015 | $7,000 | 0.0% | 4,389 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | -12.5% | 4,389 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | +33.3% | 4,389 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | 0.0% | 4,389 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | 0.0% | 4,389 | +29.3% | 0.00% | – |
| Q1 2014 | $6,000 | -14.3% | 3,394 | 0.0% | 0.00% | – |
| Q4 2013 | $7,000 | -22.2% | 3,394 | 0.0% | 0.00% | – |
| Q3 2013 | $9,000 | 0.0% | 3,394 | 0.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 3,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|